Our prior investigations in CLL cells demonstrated that SGI-1776 was cytotoxic for malignant CLL lymphocytes, and this cytotoxicity was associated with a decline in one of the early response genes (MCL-1) [7]. This evidence concerns the gene MCL1 and B-cell chronic lymphocytic leukemia.